Pathophysiology of nevi and the naevocyte;Physiopathologie des naevus et du naevocyte

Annales de Dermatologie et de Venereologie

Volumn 125, Issue 11, 1998, Pages 860-867

  Grob, J J ^a   Jreissati, M ^a  

^a HÔPITAL SAINTE MARGUERITE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN; NEVUS; PATHOGENESIS; PATHOPHYSIOLOGY; REVIEW;

GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFLAMMATION; NEVUS; RISK FACTORS; SKIN NEOPLASMS; SUNLIGHT;

EID: 0031733347     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (79)

1. Unna PG, Naevi und Naevocarcinoma. Berlin: Klin Wochenschr 1893;30:14-6.
2. Masson P. Les naevi pigmentaires. tumeurs nerveuses. Ann Anat Pathol 1926;3:417-53. 657-96.
3. Mishima Y. Part III cellular nevi: Subcellular and cytochemical characteristics with reference to their origin. Arch Dermatol 1965;91:536-57.
4. Throne EG, Mottaz JH, Zelickson AS. Tyrosinase activity in dermal nevus cells. Arch Dermatol 1971;104:619-24.
5. Nickoloff BJ, Walter R, Pregersau-Rodin, Jacobs AH, Cow AJ. Immunohistologic patterns of congenital nevocellular nevi. Arch Dermatol 1986;122:1263-8.
6. Nakajima T, Watanabe S, Sato Y, Kameyat T, Shimosato Y, Ishihara K. Immunohistochemical demonstration of S-100 protein in malignant melanomas and pigmented nevus and its diagnostic application. Cancer 1982;50:912-8.
7. De Vries TJ, Fourkour A, Wobbes T Verkroost G, Ruiter DJ, Van Muijen GN. Heterogeneous expression of immunotherapy candidate proteins gp100, MART-1, and tyrosinase in human melanoma cell lines and in human melanocytic lesions. Cancer-Res 1997;57:3223-9.
8. Stanganelli I, Rafanelli S, Bucchi L. Seasonal prevalence of digital epiluminescence microscopy patterns in acquired melanocytic nevi. J Am Acad Dermatol 1996;34:460-4.
9. Hofmann Wellenhof R, Wolf P, Smolle J, Reimann Weber A, Soyer HP, Kerl H. Influence of UVB therapy on dermoscopic features of acquired melanocytic nevi. J Am Acad Dermatol 1997;37:559-63.
10. Mancianti ML, Herlyn M, Weil D, Jambrosic J, Rodeck U, Beeker D, Diamond L, Clark W and Koprowski H. Growth and phenotoypic characteristics of human nevus cells in culture. J Invest Dermatol 1988;90:134-41.
11. Serbedzija. A vital dye analysis of the timing and pathway of avian trunk neural crest cell migration. Development 1989;106:809-16.
12. Ciment C. The melanocyte/schwann cell progenitor: a bipotent intermediate in the neural crest lineage. Comp developmental neurobiotogy 1990;14:207-23.
13. Dupin B, Schwann. Cell differentiation in clonal culture of neural crest as evidenced by the anti-SMP monoclonal antibody. PNAS 1990;87:1119-23.
14. Happle R. Mosaicism in human skin. Arch Dermatol 1993;129:1460-70.
15. Carr S, Sec J, Wilkinson B, Kossard S. Hypopigmented common blue nevus. J Cutan Pathol 1997;24:494-8.
16. Harada M, Suzuki M, Ikeda T, Kaneko T, Harada S, Fukayama M. Clonality in nevocellular nevus and melanoma: an expression-based clonality analysis at hte X-linked genes by polymerase chain reaction. J Invest Dermatol 1997;109:656-60.
17. DeDavid M, Orlow SJ, Provost N, Marghoob AA, Rao BK, Huang CL, Wasti Q, Kopf AW, Bart RS. A study of large congenital melanocytic nevi and associated malignant melanomas: review of cases in the New York University Registry and the world literature. J Am Acad Dermatol 1997;36:409-16.
18. Grob JJ, Guillaume JC, Bonerandi JJ. Doit-on préconiser l'exérèse systématique des petits naevus congénitaux '.' Ann Dermatol Venereol 1991;118:483-6.
19. Gallagher RP. Naevi appearance and disappearance. In: Grob JJ, Stern R, Mackie, Weinstock MR. Epidemiology, Causes and Prevention of Skin Diseases. Blackwell Sciences 1997;117-23.
20. Kelly JW, Rivers JK, MacLennan R, Harrison S, Lewis AE and Tate BJ. Sunlight: a major risk factor associated with development of melanocytic naevi in Australian school children. J Am Acad Dermatol 30:40-8.
21. Gallagher RP, McLean DI and Yang CP. Anatomic distribution of acquired melanocytic nevi in white children. Arch Dermatol 126:466-71.
22. Piepkorn M. A hypothesis incorporating the histologic characteristics of dysplatic nevi into the normal biological development of melanocytic nevi. Arch Dermatol 1990;126:514-8.
23. Tokudu Y, Saida T, Mukai K, Takasaki Y. Growth dynamics of acquired melanocytic nevi higher reactivity of proliferating cell nuclear antigen in junctional and compound nevi than intradermal nevi. J Am Acad Dermatol 1994;31:220-4.
24. Meyer LJ, Schmidt LA, Goldgar DE, Piepkorn MW. Survival and histopathologic characteristics of human melanocytic nevi transplanted to athymic (Nude) Mice. J Am Dermatopathol 1995;17:368-73.
25. Rallis TM, Larkin MT, Schmidt LA, Meyer LJ. Expression of c-fos in cultured human nevus cells: an increase over melanocytes and melanoma cells. Exp Dermatol 1997;6:308-13.
26. Morales Ducret J, Van de Rijn M, Smoller B. bcl-2 expression in melanocytic nevi: insights into the biology of dermal maturation. Arch Dermatol 1995;131:915-8.
27. Mengeaud V, Grob JJ, Bongrand P, Richard MA, Hesse S, Bonerandi JJ, Verrando P. Adhesive and migratory behaviors of nevus cells differ from those of epidermal melanocytes and are not linked to the histological type of nevus. J Invest Dermatol 1996;106:1224-9.
28. Tronnier M, Alexander M, Wolff H. Adhesion molecule expression in normal skin and melanocytic lesions. J Cut Pathol 1997;24:278-85.
29. Riley PA. Naevogenesis A hypothesis concerning the control of proliferation of melanocytes with special reference to the growth of intradermal naevi. Dermatology 1997;194:201-4.
30. Grob JJ, Bonerandi JJ. Sun exposure, phenotype and naevus. In: Grob JJ, Stern R, Mackie R, Weinstock M. Epidemiology. Causes and Prevention of Skin Diseases. Blackwell Sciences 1997;123-8.
31. Coleman WP, Gately LE, Krementz AB, Reed RJ, Krementz ET. Nevi, lentigines. and melanomas in Blacks. Arch Dermatol 1980;116:548-51.
32. Gallagher RP, Rivers JK, Yang PC, Mc Lean DI, Coldman AJ, Silver HKB. Melanocytic nevus density in Asian, Indo-Pakistani, and white children the Vancouver mole study. J Am Acad Dermatol 1991;2:507-12.
33. Pack GT, Davis J, Oppenheim A. The relation of race and complexion to the incidence of moles and melanoma. Ann NY Acad Sci 1963;100:719-42.
34. Armstrong BK, De Klerk NH, Holman CJ. Etiology of common acquired melanocytic nevi: constitutional variables, sun exposure and diet. JNCI 1986;77:329-35.
35. Fritschi L, Mc Henry P, Green A, MacKie R, Green L, Siskind V. Naevi in schoolchildren in Scotland and Australia Br J Dermatol 1994;130:599-603.
36. Gallagher RP, Mc Lean DI, Yang CP Coldman AJ, Silver HK, Spinelli JJ, Beagrie M. Suntan, Sunburn, and pigmentation factors and the frequency of acquired melanocytic nevi in children. Arch Dermatol 1990;12:770-6.
37. Green A, Swerdlow, V. Epidemiology of melanocytic nevi. Epidemiologic reviews 1989;1:204-21.
38. Harrisson SL, Mc Lennan R, Speare R, Wronski I. Sun exposure and melanocytic naevi in young australian children. Lancet 1994;344:1529-32.
39. Kelly JW, Rivers JK, Mac Lennan R, Harrison S, Lewis AE, Tate BJ. Sunlight: a major factor associated with the development of melanocytic nevi in Australian schoolchildren. J Am Acad Dermatol 1994;3:40-8.
40. Pope DJ, Sorahan T, Marsden JR, Ball PM, Grimley RP, Peck IM. Benign Pigmented Nevi in Children. Arch Dermatol 1992;128:1201-6.
41. Augutsson A, Stierner U, Rosdahl I, Suurkula M. Regional distribution of melanocytic naevi in relation to sun exposure, and site-specific counts predicting total number ofnaevi. Acta Derm Venereol 1990;72:123-7.
42. Augutsson A, Stierner U, Rosdahl I, Suurkula, M. Melanocytic naevi in sun-exposed and protected skin in melanoma patients and controls. Acta Derm Venereol 1992;7:512- 517.
43. English, DR, BK Armstrong Melanocytic nevi in children. Anatomic Sites and Demographic and Host Factors. Am J Epid 1994;13:390-401.
44. Gallagher, RP, Mc Lean, DI, Yang CP, Coldman AJ, Silver HK, Spinelli JJ, Beagrie M. Anatomic distribution of Acquired Melanocytic Nevi in White Children. A comparison with melanoma: the Vancouver Mole Study. Arch Dermatol 1990;126:466-71.
45. Richard MA, Grob JJ, Gouvernet J, Culat P, Normand P, Zarour H, el al. Role of. sun exposure on nevus. First study in age-sex-phenotype controlled populations. Arch Dermatol 1993;129:1280-85.
46. English DR, Armstrong BK. Melanocytic nevi in children. Observer variation in Counting nevi. Am J Epid 1994;139:402-7.
47. Garbe C, Buttner P, Weib J, Soyer HP, Stocker U, Krüger S, et al. Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines multicenter case-control study of the central malignant melanoma registry of the German dermatological society. J Invest Dermatol 1994;102:700-5.
48. Luther H, Altmeyer P, Garbe C, Ellwanger U, Jahn S, Hoffmann K, Segerling M. Increase of melanocytic nevus counts in children during 5 years of follow-up and analysis of associated factors. Arch Dermatol 1996;132:1473-8.
49. Holman CD, Armstrong BK. Pigmentary traits, ethnic origin, benign nevi, and family history as risk factors for cutaneous malignant melanoma J Natl Cancer Inst 1984;72:257-66.
50. Roudil F, Grob JJ, Gouvernet J, Richard MA, Basseres N, Bonerandi JJ. Influence of sun exposure after chilhood on the development of nevi. Eur J Dermatol 1995;5:477-80.
51. Tronnier M, Smolle J, Wolff H. Ultraviolet irradiation induces acute changes in melanocytic nevi. J Invest Dermatol 1995;104:475-8.
52. Tronnier M, Rudolph P, Koser T, Raasch B, Brinckmann J. One single erythemagenic UV irradiation is more effective in increasing the proliferative activity of melanocytes in melanocytic naevi compared with fractionally applied high doses. Br J Dermat 1997;137:534-9.
53. Dooley P, Mattern VL, Moore CM, Porter PA, Robinson ES, Vandeberg JL. Cell lines derived from ultraviolet radiation-induced benign melanocytic nevi in monodelphis domestica exhibit cytogenetic aneuploidy. Cancer Genet Cytogenet 1993;71:55-66.
54. Hughes BR, Cunliffe WJ, Bailey C. Excess benign melanocytic naevi after chemotherapy for malignancy in childhood. Br Med J 1989;299:88-91.
55. DeWit P, De Vann G, De Boo T. Prevalence of naevocytic naevi after chemotherapy for childhood cancer. Med Paediatr Oncoll 1990;18:336.
56. Green A, Smith P, Mc Whirter W, O Regan P, Battistutta D, Yarker ME, Lape K. Melanocytic nevi and melanoma in survivals of chilhood cancer. Br J Cancer 1993;67:1053.
57. Barker JN, Donald DM. Eruptive dysplastic nevi following renal transplantation. Clin Exp Dermatol 1988;13:123.
58. Smith CH, McGregor JM, Barker JNWN, Morris RW, Ridgen SPA, MacDonald D. M. Excess melanocytic nevi in children with renal allografts. J Am Acad Dermatol 1933;28:51.
59. Grob JJ, Bastuji S, Vaillant L, Roujeau JC, Bernard P, Sassolas S, Guillaume JC. Excess nevi related to immunodeficiency A study in HIV infected patients and renal transplant recipients. J Invest Dermatol 1996;107:694-7.
60. Szepietowski J, Wasik F, Szepietowski T, Wlodarczyk M, Sobczak Radwan K, Czyz W. Excess benign melanocytic naevi in renal transplant recipients. Dermatology 1997;194:17-9.
61. Pierard GE, Pierard Franchimont C, Nikkels A, Nikkels Tassoudji N, Arrese J Naevocyte triggering by recombinant human growth hormone. J Pathol 1996;180:74-9.
62. Zvulunov A, Wyatt D, Laud P, Esterly N. Lack of effect of growth hormone therapy on the count and density of melanocytic naevi in children. Br J Dermatol 1997;137:545-8.
63. Jemec BG, Bhogal BS, Wojnarowska F. Are acquired nevi oestrogen dependent tumours ? Acta Derm Venereol 1987;67:451-3.
64. Thompson AJ, Cook MG, Gill PG. Immunofluorescent detection of hormone receptors in cutaneous melanocytic tumours. Br J Cancer 1981;43:644-53.
65. Clark W. H, Reimer R, Greene M, Ainsworth A. M, Manstragelo M. J. Origin of familial malignant melanomas from heritable melanocytic lesions: The B.K. mole syndrome. Arch Dermatol 1978;114:732-38.
66. Moriwaki SI, Tarone RE, Tucker MA, Goldstein AM, Kraemer KH. Hypermutability of UV treated plasmids in dysplastic nevus/familial melanoma cell lines. Cancer Res 1997;57:4637-41.
67. Sanford KK, Parshad R, Price FM, Tarone RE, Thompson J, Guerry D. Radiation induced chromatid breaks and DNA repair in blood lymphocytes of patients with dysplastic nevi and/or cutaneous melanoma. J Invest Dermatol 1947;109:546-9.
68. Bale SJ, Dracopolin C, Tucker MA, Clark WH, Fraser MC, Stanger BZ, Green P, Donis-Keller H, Housman DE, Greene MH. Mapping the gene for hereditary cutaneous malignant melanoma-dysplastic nevus to chromosome lp. N Engl J Med 1989;320:1367-72.
69. Cannon-Albright LA, Goldgar DE, Meyer LJ, Lewis CM, Anderson DE, Fountain JW, Hegi ME, Wiseman RW, Petty EM, Bale AE, Olopade OI, Kwiatkowski DJ, Piepkorn M, Zone JJ, Skolnick MH. Assignement of a locus for familial malignant melanoma MLM to chromosome 9p13-p22. Science 1992;258:1148-52.
70. Soufir N, Avril MF, Chompret A. Prévalence of the p16 and CDK4 germline mutations, in 48 melanoma-prone families in France. Hum Mol Genet 1998;7:209-16.
71. Greene MH. Genetics of cutaneous melanoma and nevi. Mayo Clin Proc 1997;72:467-74.
72. Duffy DL, MacDonald AM, Easton DF, Ponder BAJ, Martin NG. Is the genetic of moliness simply the genetics of sun exposure ? A path analysis of nevus counts and risk factors in British twins. Cytogenet Cell Genet 1992;54:194-6.
73. Grob JJ. Pourquoi les naevus disparaissent-ils aux approches de la vieillesse ? Ann Dermatol Venereol 1998;125:237-38.
74. Harth Y, Friedman-Birnbaum R, Shai Linn. Influence of cumulative sun exposure on the prevalence of common acquired nevi. J Am Acad Dermatol 1992;27:21-4.
75. Krebs JA et al. Halo nevus: Competent surveillance of potential melanoma ? Cleve Clin Q 1976;43:11-5.
76. Levin D, Wilson K, Valadares de Amorin G, Webber J, Kenny P, Kusser W. Detection of p53 mutations in benign and dysplastic nevi. Cancer Research 1995;55:4278-82.
77. Bonerandi JJ, Grob JJ. Reflexions à propos des syndromes du naevus dysplasiques. Ann Dermatol Venereol 1986;113:847-50.
78. Grob JJ, Bonerandi JJ. Naevus atypique ou naevus dysplasique. Objectif peau 1994;2:2-5.
79. Grob JJ, Gouvernet J. Aymar D, Mostaque A, Romano MH, Collet AM, Bonerandi JJ. Count of benign melanocytic nevi as a major indicator of risk for non familial nodular and superficial spreading and nodular melanoma. Cancer 1990;66:387-95.